SE9100341D0 - Novel steroids - Google Patents

Novel steroids

Info

Publication number
SE9100341D0
SE9100341D0 SE9100341A SE9100341A SE9100341D0 SE 9100341 D0 SE9100341 D0 SE 9100341D0 SE 9100341 A SE9100341 A SE 9100341A SE 9100341 A SE9100341 A SE 9100341A SE 9100341 D0 SE9100341 D0 SE 9100341D0
Authority
SE
Sweden
Prior art keywords
pct
compounds
date aug
sec
fluorine atom
Prior art date
Application number
SE9100341A
Other languages
English (en)
Inventor
P Andersson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of SE9100341D0 publication Critical patent/SE9100341D0/sv
Priority to SE9100341A priority Critical patent/SE9100341D0/sv
Application filed by Astra Ab filed Critical Astra Ab
Priority to IL10053291A priority patent/IL100532A/en
Priority to NZ241210A priority patent/NZ241210A/xx
Priority to PH43757A priority patent/PH31284A/en
Priority to ZA92233A priority patent/ZA92233B/xx
Priority to IE016692A priority patent/IE920166A1/en
Priority to SI9210065A priority patent/SI9210065B/sl
Priority to DZ920005A priority patent/DZ1553A1/fr
Priority to YU6592A priority patent/YU48892B/sh
Priority to APAP/P/1992/000353A priority patent/AP366A/en
Priority to MX9200324A priority patent/MX9200324A/es
Priority to AT92904566T priority patent/ATE178611T1/de
Priority to US08/094,207 priority patent/US5674861A/en
Priority to RU93053630A priority patent/RU2111212C1/ru
Priority to CS931496A priority patent/CZ281685B6/cs
Priority to UA93004261A priority patent/UA41267C2/uk
Priority to ES92904566T priority patent/ES2133315T3/es
Priority to PL92300350A priority patent/PL170000B1/pl
Priority to HU9302244A priority patent/HU218275B/hu
Priority to KR1019930702298A priority patent/KR100216720B1/ko
Priority to CA002103924A priority patent/CA2103924A1/en
Priority to SK796-93A priority patent/SK281801B6/sk
Priority to EP92904566A priority patent/EP0570454B1/en
Priority to DE69228870T priority patent/DE69228870T2/de
Priority to SG1996005993A priority patent/SG52557A1/en
Priority to DK92904566T priority patent/DK0570454T3/da
Priority to JP4504216A priority patent/JPH06505232A/ja
Priority to RO93-01095A priority patent/RO111195B1/ro
Priority to PCT/SE1992/000055 priority patent/WO1992013872A1/en
Priority to AU12307/92A priority patent/AU661471C/en
Priority to PT100086A priority patent/PT100086B/pt
Priority to MA22692A priority patent/MA22406A1/fr
Priority to CN92100800A priority patent/CN1034868C/zh
Priority to IS3808A priority patent/IS1601B/is
Priority to TNTNSN92007A priority patent/TNSN92007A1/fr
Priority to BG97971A priority patent/BG62211B1/bg
Priority to NO932761A priority patent/NO304073B1/no
Priority to FI933450A priority patent/FI933450A/fi
Priority to EE9400349A priority patent/EE03111B1/xx
Priority to CN96100576A priority patent/CN1052155C/zh
Priority to CN96100575A priority patent/CN1058724C/zh
Priority to US08/944,676 priority patent/US5939409A/en
Priority to HK98111582A priority patent/HK1010733A1/xx
Priority to GR990401743T priority patent/GR3030657T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0092—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by an OH group free esterified or etherified
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SE9100341A 1991-02-04 1991-02-04 Novel steroids SE9100341D0 (sv)

Priority Applications (44)

Application Number Priority Date Filing Date Title
SE9100341A SE9100341D0 (sv) 1991-02-04 1991-02-04 Novel steroids
IL10053291A IL100532A (en) 1991-02-04 1991-12-26 History of steroids, the process for their preparation and medicinal preparations containing them
NZ241210A NZ241210A (en) 1991-02-04 1992-01-06 16alpha,17alpha-butylidenedioxy-11b, 21-dihydroxypregn-4-ene-3,20-dione derivatives substituted in either or both the 6alpha- and 9alpha- positions by fluorine; pharmaceutical compositions, methods of preparation and treatment
PH43757A PH31284A (en) 1991-02-04 1992-01-10 Fluorinated steriods.
ZA92233A ZA92233B (en) 1991-02-04 1992-01-13 Novel steroids
IE016692A IE920166A1 (en) 1991-02-04 1992-01-21 Novel steroids, their preparation and pharmaceutical use
YU6592A YU48892B (sh) 1991-02-04 1992-01-22 Novi steroidi
SI9210065A SI9210065B (en) 1991-02-04 1992-01-22 Novel antiinflamatory and antialergic active compounds, glucocorticosteroids and processes for their preparation
DZ920005A DZ1553A1 (fr) 1991-02-04 1992-01-22 Nouveaux steroïdes.
APAP/P/1992/000353A AP366A (en) 1991-02-04 1992-01-27 Novel Steroids.
MX9200324A MX9200324A (es) 1991-02-04 1992-01-27 Nuevos esteroides, procedimiento para su preparacinuevos esteroides, procedimiento para su preparacion y composicion farmaceutica que los contiene. on y composicion farmaceutica que los contiene.
AU12307/92A AU661471C (en) 1991-02-04 1992-01-29 Novel steroids
CA002103924A CA2103924A1 (en) 1991-02-04 1992-01-29 Novel steroids
PCT/SE1992/000055 WO1992013872A1 (en) 1991-02-04 1992-01-29 Novel steroids
RU93053630A RU2111212C1 (ru) 1991-02-04 1992-01-29 22r- или 22s-эпимеры соединения, способ их получения, фармацевтическая композиция и способ лечения аллергических и воспалительных заболеваний
CS931496A CZ281685B6 (cs) 1991-02-04 1992-01-29 Nové steroidy
UA93004261A UA41267C2 (uk) 1991-02-04 1992-01-29 Глюкокортикостероїди, спосіб їх отримання (варіанти), фармацевтична композиція
ES92904566T ES2133315T3 (es) 1991-02-04 1992-01-29 Nuevos esteroides.
PL92300350A PL170000B1 (pl) 1991-02-04 1992-01-29 Sposób wytwarzania 16,17 acetali pregnanu PL PL PL PL PL PL PL PL
HU9302244A HU218275B (en) 1991-02-04 1992-01-29 New steroide derivatives, medicaments containing the same and process for their production
KR1019930702298A KR100216720B1 (ko) 1991-02-04 1992-01-29 신규 스테로이드
AT92904566T ATE178611T1 (de) 1991-02-04 1992-01-29 Neue steroide
SK796-93A SK281801B6 (sk) 1991-02-04 1992-01-29 Steroidy, spôsob ich prípravy, farmaceutický prostriedok s ich obsahom a ich použitie
EP92904566A EP0570454B1 (en) 1991-02-04 1992-01-29 Novel steroids
DE69228870T DE69228870T2 (de) 1991-02-04 1992-01-29 Neue steroide
SG1996005993A SG52557A1 (en) 1991-02-04 1992-01-29 Novel steroids
DK92904566T DK0570454T3 (da) 1991-02-04 1992-01-29 Hidtil ukendte steroider
JP4504216A JPH06505232A (ja) 1991-02-04 1992-01-29 新規ステロイド
RO93-01095A RO111195B1 (ro) 1991-02-04 1992-01-29 Derivati de glucocorticosteroizi, procedeu pentru prepararea acestora si compozitie farmaceutica, pe baza de acesti compusi
US08/094,207 US5674861A (en) 1991-02-04 1992-01-29 Fluorinated steroids
PT100086A PT100086B (pt) 1991-02-04 1992-02-03 Epimeros de esteroides de 16alfa, 17alfa-butilidenodioxi-11beta, 21-di-hidroxipregn-4-eno-3,20-diona fluoro-substituidos
IS3808A IS1601B (is) 1991-02-04 1992-02-03 Hliðstæð aðferð við framleiðslu á nýjum 22R og 22S epimerum af sykursterum
MA22692A MA22406A1 (fr) 1991-02-04 1992-02-03 Nouveaux steroides
CN92100800A CN1034868C (zh) 1991-02-04 1992-02-03 6α，9α-二氟-孕甾-3，20-二酮类化合物的制备方法
TNTNSN92007A TNSN92007A1 (fr) 1991-02-04 1992-02-04 Nouveaux steroides
BG97971A BG62211B1 (bg) 1991-02-04 1993-07-20 Нови стероиди
NO932761A NO304073B1 (no) 1991-02-04 1993-08-02 Nye steroider, farmasöytisk preparat inneholdende disse forbindelsene og deres anvendelse
FI933450A FI933450A (fi) 1991-02-04 1993-08-03 Nya steroider
EE9400349A EE03111B1 (et) 1991-02-04 1994-11-03 Glükokortikosteroidi epimeerid, nende valmistamise protsessid ja neid sisaldavad ravimpreparaadid
CN96100576A CN1052155C (zh) 1991-02-04 1996-04-30 含新的甾族化合物的药物组合物的制法
CN96100575A CN1058724C (zh) 1991-02-04 1996-04-30 新的甾族化合物在制药中的应用
US08/944,676 US5939409A (en) 1991-02-04 1997-10-07 Processes for the production of anti-inflammatory steroids
HK98111582A HK1010733A1 (en) 1991-02-04 1998-10-29 Novel steroids
GR990401743T GR3030657T3 (en) 1991-02-04 1999-06-30 Novel steroids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9100341A SE9100341D0 (sv) 1991-02-04 1991-02-04 Novel steroids

Publications (1)

Publication Number Publication Date
SE9100341D0 true SE9100341D0 (sv) 1991-02-04

Family

ID=20381806

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9100341A SE9100341D0 (sv) 1991-02-04 1991-02-04 Novel steroids

Country Status (40)

Country Link
US (2) US5674861A (sv)
EP (1) EP0570454B1 (sv)
JP (1) JPH06505232A (sv)
KR (1) KR100216720B1 (sv)
CN (3) CN1034868C (sv)
AP (1) AP366A (sv)
AT (1) ATE178611T1 (sv)
BG (1) BG62211B1 (sv)
CA (1) CA2103924A1 (sv)
CZ (1) CZ281685B6 (sv)
DE (1) DE69228870T2 (sv)
DK (1) DK0570454T3 (sv)
DZ (1) DZ1553A1 (sv)
EE (1) EE03111B1 (sv)
ES (1) ES2133315T3 (sv)
FI (1) FI933450A (sv)
GR (1) GR3030657T3 (sv)
HK (1) HK1010733A1 (sv)
HU (1) HU218275B (sv)
IE (1) IE920166A1 (sv)
IL (1) IL100532A (sv)
IS (1) IS1601B (sv)
MA (1) MA22406A1 (sv)
MX (1) MX9200324A (sv)
NO (1) NO304073B1 (sv)
NZ (1) NZ241210A (sv)
PH (1) PH31284A (sv)
PL (1) PL170000B1 (sv)
PT (1) PT100086B (sv)
RO (1) RO111195B1 (sv)
RU (1) RU2111212C1 (sv)
SE (1) SE9100341D0 (sv)
SG (1) SG52557A1 (sv)
SI (1) SI9210065B (sv)
SK (1) SK281801B6 (sv)
TN (1) TNSN92007A1 (sv)
UA (1) UA41267C2 (sv)
WO (1) WO1992013872A1 (sv)
YU (1) YU48892B (sv)
ZA (1) ZA92233B (sv)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9100341D0 (sv) * 1991-02-04 1991-02-04 Astra Ab Novel steroids
CZ171095A3 (en) * 1993-01-08 1996-01-17 Astra Ab Novel steroidal derivatives specific for colon or ilium
US5983956A (en) 1994-10-03 1999-11-16 Astra Aktiebolag Formulation for inhalation
US5980949A (en) * 1994-10-03 1999-11-09 Astra Aktiebolag Formulation for inhalation
GB9423919D0 (en) * 1994-11-26 1995-01-11 Rhone Poulenc Rorer Ltd Chemical process
SE9700133D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
IT1291288B1 (it) * 1997-04-30 1999-01-07 Farmabios Srl Processo per la preparazione di 16,17 acetali di derivati pregnanici con controllo della distribuzione epimerica al c-22.
CA2330611A1 (en) 1998-05-22 1999-12-02 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
GB0009607D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medical compositions
GB0009592D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory combinations
HRP20010018A2 (en) 2001-01-09 2002-12-31 Pliva D D Novel anti-inflammatory compounds
GB0110411D0 (en) * 2001-04-27 2001-06-20 Astrazeneca Ab Chemical process
EP1465915A1 (en) * 2001-09-25 2004-10-13 PHARMACIA & UPJOHN COMPANY Stereoselective transacetalization of steroidal c-22 acetonide
AU2003264917A1 (en) 2002-07-08 2004-01-23 Pliva - Istrazivacki Institut D.O.O. Hybrid molecules of macrolides with steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules
JP4790263B2 (ja) 2002-07-08 2011-10-12 グラクソ グループ リミテッド 炎症性の疾患および病態を治療する新規な化合物、組成物および方法
WO2004017904A2 (en) * 2002-08-23 2004-03-04 The Mclean Hospital Corporation Corticosteroid conjugates and uses thereof
TW200417371A (en) * 2003-02-21 2004-09-16 Upjohn Co A continuous process for the production of R-rofleponide
HRP20030324A2 (en) 2003-04-24 2005-02-28 Pliva-Istra�iva�ki institut d.o.o. Compounds of antiinflammatory effect
HRP20030603A2 (en) 2003-07-25 2005-10-31 Pliva-Istra�iva�ki institut d.o.o. Substituted furochromene compounds of antiinflammatory action
HRP20030604A2 (en) 2003-07-25 2005-04-30 Pliva-Istra�iva�ki institut d.o.o. Substituted furochromenes, preparation thereof andtheir antiinflammatory action
JP2008517993A (ja) 2004-10-27 2008-05-29 グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ 抗炎症作用を有するコンジュゲート
WO2006116718A2 (en) 2005-04-28 2006-11-02 Proteus Biomedical, Inc. Pharma-informatics system
WO2007008155A1 (en) * 2005-07-11 2007-01-18 Astrazeneca Ab New combination 1
JP2009508494A (ja) 2005-09-16 2009-03-05 ラプトール ファーマシューティカル インコーポレイテッド Ｃｒを含むタンパク質に対して特異的な受容体−結合タンパク質（ｒａｐ）変異体を含む組成物およびその使用
WO2008100560A2 (en) * 2007-02-14 2008-08-21 University Of Southern California Estrogen receptor modulators, associated pharmaceutical compositions and methods of use
WO2010095940A2 (en) 2009-02-20 2010-08-26 To-Bbb Holding B.V. Glutathione-based drug delivery system
KR101741629B1 (ko) 2009-05-06 2017-05-31 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3126375A (en) * 1964-03-24 Chioacyl
US3048581A (en) * 1960-04-25 1962-08-07 Olin Mathieson Acetals and ketals of 16, 17-dihydroxy steroids
US3357974A (en) * 1965-12-28 1967-12-12 Merck & Co Inc Processes for preparing 16alpha, 17alpha-acetals and ketals of 16alpha, 17alpha, 21-trihydroxy-delta4-pregnene-3, 20-diones
US3758686A (en) * 1971-12-07 1973-09-11 American Cyanamid Co Method of using steroid acetonides
SE378110B (sv) * 1972-05-19 1975-08-18 Bofors Ab
SE378109B (sv) * 1972-05-19 1975-08-18 Bofors Ab
SE8008524L (sv) * 1980-12-04 1982-06-05 Draco Ab 4-pregnen-derivat, ett forfarande for deras framstellning, beredning och metod for behandling av inflammatoriska tillstand
US4749649A (en) * 1983-05-16 1988-06-07 The Upjohn Company Microbial Δ1-dehydrogenation process using a scavenger of toxic oxygen
IT1196142B (it) * 1984-06-11 1988-11-10 Sicor Spa Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti
SE8403905D0 (sv) * 1984-07-30 1984-07-30 Draco Ab Liposomes and steroid esters
CN1060471A (zh) * 1985-04-04 1992-04-22 得拉科公司 新的16，17-缩醛取代雄甾烷-17β-酮类的制备方法
SE8604059D0 (sv) * 1986-09-25 1986-09-25 Astra Pharma Prod A method of controlling the epimeric distribution in the preparation of 16,17-acetals of pregnane derivatives
HU203769B (en) * 1989-03-09 1991-09-30 Richter Gedeon Vegyeszet Process for producing new steroide derivatives and pharmaceutical compositions containing them
HU203562B (en) * 1989-03-09 1991-08-28 Richter Gedeon Vegyeszet Process for producing new steroide diols and pharmaceutical compositions containing them
PL164294B1 (pl) * 1990-12-20 1994-07-29 Inst Farmaceutyczny Sposób otrzymywania diastereoizomeru /22R/-16a , 17a-butylidenodioksy-11 ß 21-dihydroksy-1,4-pregnadien-3,20-dionu PL
SE9100342D0 (sv) * 1991-02-04 1991-02-04 Astra Ab Novel steroid esters
SE9100341D0 (sv) * 1991-02-04 1991-02-04 Astra Ab Novel steroids

Also Published As

Publication number Publication date
MA22406A1 (fr) 1992-10-01
MX9200324A (es) 1992-09-01
UA41267C2 (uk) 2001-09-17
NZ241210A (en) 1993-08-26
EE03111B1 (et) 1998-08-17
FI933450A0 (fi) 1993-08-03
BG97971A (bg) 1994-04-29
CZ149693A3 (en) 1994-03-16
CN1064079A (zh) 1992-09-02
DE69228870D1 (de) 1999-05-12
NO932761L (no) 1993-08-02
AU1230792A (en) 1992-09-07
HK1010733A1 (en) 1999-06-25
YU48892B (sh) 2002-10-18
ATE178611T1 (de) 1999-04-15
AP366A (en) 1994-10-21
JPH06505232A (ja) 1994-06-16
SI9210065B (en) 2001-12-31
CN1140059A (zh) 1997-01-15
NO932761D0 (no) 1993-08-02
IL100532A0 (en) 1992-09-06
CN1140178A (zh) 1997-01-15
DK0570454T3 (da) 1999-10-18
SK281801B6 (sk) 2001-08-06
US5939409A (en) 1999-08-17
US5674861A (en) 1997-10-07
SI9210065A (en) 1995-02-28
CA2103924A1 (en) 1992-08-05
GR3030657T3 (en) 1999-10-29
IL100532A (en) 1996-05-14
NO304073B1 (no) 1998-10-19
YU6592A (sh) 1995-01-31
WO1992013872A1 (en) 1992-08-20
HUT64973A (en) 1994-03-28
SG52557A1 (en) 1998-09-28
IS1601B (is) 1996-10-18
IE920166A1 (en) 1992-08-12
CN1052155C (zh) 2000-05-10
RU2111212C1 (ru) 1998-05-20
PH31284A (en) 1998-07-06
HU218275B (en) 2000-07-28
TNSN92007A1 (fr) 1993-06-08
EP0570454A1 (en) 1993-11-24
FI933450A (fi) 1993-08-03
AP9200353A0 (en) 1992-01-31
PT100086A (pt) 1994-05-31
DE69228870T2 (de) 1999-08-19
HU9302244D0 (en) 1993-10-28
CN1034868C (zh) 1997-05-14
PT100086B (pt) 1999-06-30
BG62211B1 (bg) 1999-05-31
ZA92233B (en) 1992-10-28
AU661471B2 (en) 1995-07-27
CN1058724C (zh) 2000-11-22
CZ281685B6 (cs) 1996-12-11
PL170000B1 (pl) 1996-10-31
IS3808A (is) 1992-08-05
KR100216720B1 (ko) 1999-10-01
ES2133315T3 (es) 1999-09-16
SK79693A3 (en) 1994-03-09
EP0570454B1 (en) 1999-04-07
DZ1553A1 (fr) 2002-02-17
RO111195B1 (ro) 1996-07-30

Similar Documents

Publication Publication Date Title
SE9100341D0 (sv) Novel steroids
SE9100342D0 (sv) Novel steroid esters
KR950700894A (ko) 탁솔 유도체(Taxol derivatives)
BR9408246A (pt) Composto derivado de 3-azabicicloalcano N-substituído
FI932229A (fi) Azabicykliska bryggderivat
SG55184A1 (en) New imidazopyridines
AU2534288A (en) Heterocyclic compounds
ES2193241T3 (es) Nuevas n-2-oxo2.3.4.5-tetrajodrp-1h-1,5-benzodiazepin-3-il)-3-amidas.
DK0730581T3 (da) 3-acylaminobezazepiner
NO941958D0 (no) Fremstilling av substituerte piperidiner
ES8800122A1 (es) Un procedimiento para la preparacion de derivados de indeno y naftaleno.
DK0696278T3 (da) Herbicidtvirkende substituerede 1-phenyl- eller 1-pyridinylbenzotriazoler
CS9100438A2 (en) New derivative of beta-phenylisoserine, method of its preparation and its application
DE69413831D1 (de) Phenoxyphenylcyclopentenyl-hydroxyharnstoffe
DE59307133D1 (de) Gestagen wirksame 19,11-überbrückte 4-estrene
ES479033A1 (es) Un procedimiento para la preparacion de derivados de n-iminometil piperidina.
FI933231A0 (fi) Acylaminoalkylidenhydroxibisfosfonsyror anvaendningsbara vid terapi av benledsjukdomar
ES2125893T3 (es) 2-amino-1,3,4-tiadiazoles aminoalquilsubstituidos, su obtencion y su empleo.
ATE207480T1 (de) Substituierte aminoalkylaminopyridine
ATE81508T1 (de) Herstellung von corticoiden aus steroidischen 17- cyanohydrinen.
JPS5283567A (en) N-containing, 6-membered quaternary compounds
YU49004B (sh) LANOSTA-7,9-DIEN-3Гџ, 32-DIOL I POSTUPAK ZA NJEGOVO DOBIJANJE
NO940984L (no) Benzen-derivater
FI946009A (sv) Användning av antikärnfärgningsmedel vid framställning av cellplaster baserade på isocyanat